← Snapshot 21

Orange Book snapshot 21: Products

Products page 94 of 799 · 39,901 matching rows.

Source row, Application type, Application number table
Source rowApplication typeApplication numberProduct numberIngredient rawDosage form / route rawDosage formRouteTrade nameApplicantStrength rawTE rawTE JSONApproval dateApproval date rawApproved before 1982RLDRSProduct typeApplicant full nameRaw row SHA-256
4652A061443002TETRACYCLINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALRETETSOLVAY500MG[]Approved Prior to Jan 1, 1982YesNoNoDISCNSOLVAY PHARMACEUTICALS21145c7c05595cb79d743048ae873b9285061dd2483e6b43baae124516b4302f
4653N213246001SELPERCATINIBCAPSULE;ORALCAPSULEORALRETEVMOLOXO ONCOLOGY INC40MG[]2020-05-08May 8, 2020NoYesNoRXLOXO ONCOLOGY INC455e34426aed8f4ebe2cb72bcfe6e8913b57562d1c1183557f98dc6d4f4fdf94
4654N213246002SELPERCATINIBCAPSULE;ORALCAPSULEORALRETEVMOLOXO ONCOLOGY INC80MG[]2020-05-08May 8, 2020NoYesYesRXLOXO ONCOLOGY INC3a9768ae8d90f9090191697ddff60adc3def6353a05fc9065e8013917b6c4901
4655N019655001ZIDOVUDINECAPSULE;ORALCAPSULEORALRETROVIRVIIV HLTHCARE100MGAB["AB"]1987-03-19Mar 19, 1987NoYesYesRXVIIV HEALTHCARE CO434390d316f2d67579b545a3966e9973c63228e7a842483dbae5dcd60641c7e1
4656N021880005LENALIDOMIDECAPSULE;ORALCAPSULEORALREVLIMIDCELGENE2.5MG[]2011-12-21Dec 21, 2011NoYesNoRXCELGENE CORPb89a1e2be5a1235e2a3d27c47d82e4455893406038009d6d5ca7528915c01347
4657N021880001LENALIDOMIDECAPSULE;ORALCAPSULEORALREVLIMIDCELGENE5MG[]2005-12-27Dec 27, 2005NoYesNoRXCELGENE CORP0c622453af639f6c866831e7cf8a63ec511d71ef8fc7958e8e0be43fde929baf
4658N021880002LENALIDOMIDECAPSULE;ORALCAPSULEORALREVLIMIDCELGENE10MG[]2005-12-27Dec 27, 2005NoYesNoRXCELGENE CORPa822e56618bce982c76c27bae53ef6a7c61b3227d37c7733cf249b74dd886cf6
4659N021880003LENALIDOMIDECAPSULE;ORALCAPSULEORALREVLIMIDCELGENE15MG[]2006-06-29Jun 29, 2006NoYesNoRXCELGENE CORPb6eba21293cda5c93db9b28d3e3caad20aa7794ce1483372dd7f375f923c8db4
4660N021880006LENALIDOMIDECAPSULE;ORALCAPSULEORALREVLIMIDCELGENE20MG[]2013-06-05Jun 5, 2013NoYesNoRXCELGENE CORP05692b7df8281fdbca9a98587959991a5e1b48d7d9c8f6af9379ef17302d3f5b
4661N021880004LENALIDOMIDECAPSULE;ORALCAPSULEORALREVLIMIDCELGENE25MG[]2006-06-29Jun 29, 2006NoYesYesRXCELGENE CORPecef83b441daeb1f8a1b22122350e5e899e95d3f3ad543953e9b640b689c376e
4662N021567001ATAZANAVIR SULFATECAPSULE;ORALCAPSULEORALREYATAZBRISTOL MYERS SQUIBBEQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**[]2003-06-20Jun 20, 2003NoYesNoDISCNBRISTOL MYERS SQUIBB COfa9a034d2fa6faae3502bc7990a73c0c0f8623e79e960b81b1c7461ecc0c3b5b
4663N021567002ATAZANAVIR SULFATECAPSULE;ORALCAPSULEORALREYATAZBRISTOL MYERS SQUIBBEQ 150MG BASEAB["AB"]2003-06-20Jun 20, 2003NoYesNoRXBRISTOL MYERS SQUIBB CO38ee274798b5e64ecf0bec4cbf815824f925bc0f9087502c16a25f2ee0cb41f5
4664N021567003ATAZANAVIR SULFATECAPSULE;ORALCAPSULEORALREYATAZBRISTOL MYERS SQUIBBEQ 200MG BASEAB["AB"]2003-06-20Jun 20, 2003NoYesNoRXBRISTOL MYERS SQUIBB CO9af53a67f51451676a265d9e1097dc6ab69a9c1e1018e5a09576be6dadd80591
4665N021567004ATAZANAVIR SULFATECAPSULE;ORALCAPSULEORALREYATAZBRISTOL MYERS SQUIBBEQ 300MG BASEAB["AB"]2006-10-16Oct 16, 2006NoYesYesRXBRISTOL MYERS SQUIBB CO003791ef3866b7e0bb37300efcbda260c90853acda8a924673b0937d003144a0
4666A076203001RIBAVIRINCAPSULE;ORALCAPSULEORALRIBASPHERECHARTWELL RX200MG[]2004-04-06Apr 6, 2004NoNoNoDISCNCHARTWELL RX SCIENCES LLC40aeb2f6606477d1c8da83d2b2e977e656fc0c755f389190a18516958ac14643
4667A079117001RIBAVIRINCAPSULE;ORALCAPSULEORALRIBAVIRINAUROBINDO PHARMA200MGAB["AB"]2009-09-17Sep 17, 2009NoNoNoRXAUROBINDO PHARMA LTD46ee178966f7b22b6fd403657d308bb0b76291ce362535855635cb15d3dd9914
4668A076192001RIBAVIRINCAPSULE;ORALCAPSULEORALRIBAVIRINCHARTWELL RX200MG[]2004-04-06Apr 6, 2004NoNoNoDISCNCHARTWELL RX SCIENCES LLCece6dc881a271c517e3bf038b8990361d4e74b156093ebc23076efc55d40084a
4669A076277001RIBAVIRINCAPSULE;ORALCAPSULEORALRIBAVIRINTEVA200MG[]2004-10-04Oct 4, 2004NoNoNoDISCNTEVA PHARMACEUTICALS USA INCdb0452c7dc74c3b2e5c5fdc27fcf9b3811afecbc368bc566c8b31c0c578503e8
4670A077224001RIBAVIRINCAPSULE;ORALCAPSULEORALRIBAVIRINZYDUS PHARMS USA200MGAB["AB"]2005-10-28Oct 28, 2005NoNoNoRXZYDUS PHARMACEUTICALS USA INCe51419cf051ebba8d0b1cf7d43f88b58d4b403ea84ea6048c00a7002ddd8b95b
4671N018689001AURANOFINCAPSULE;ORALCAPSULEORALRIDAURASEBELA IRELAND LTD3MG[]1985-05-24May 24, 1985NoYesYesRXSEBELA IRELAND LTDc4b1e683f2223a8d16e3c72282611e48781b2323f7416bfd0b98e6570bf7b15e
4672A090033001RIFABUTINCAPSULE;ORALCAPSULEORALRIFABUTINLUPIN LTD150MGAB["AB"]2014-02-24Feb 24, 2014NoNoNoRXLUPIN LTD5f427cea0ac5afbaaacef4e657a9d08d3bb79e9859e2b1c6372d87696bf9619a
4673A062303001RIFAMPINCAPSULE;ORALCAPSULEORALRIFADINSANOFI AVENTIS US150MG[]Approved Prior to Jan 1, 1982YesNoNoDISCNSANOFI AVENTIS US LLC9315b3b19040149938f3620ed9cd42d7ccfae97f1b7334811a7c32604c1c59f0
4674N050420001RIFAMPINCAPSULE;ORALCAPSULEORALRIFADINSANOFI AVENTIS US300MG[]Approved Prior to Jan 1, 1982YesYesNoDISCNSANOFI AVENTIS US LLCd1f5347df30f1652d92ac165528e15b88ce9285e85d91e846849a25fd3f34fc1
4675A061884001ISONIAZID; RIFAMPINCAPSULE;ORALCAPSULEORALRIFAMATESANOFI AVENTIS US150MG;300MG[]Approved Prior to Jan 1, 1982YesNoNoDISCNSANOFI AVENTIS US LLC17f74bbbdc5585179ed27c962d942bc5c24c5f62c99ca674e6f3593b2c71c819
4676A065028001RIFAMPINCAPSULE;ORALCAPSULEORALRIFAMPINAKORN150MGAB["AB"]2001-03-14Mar 14, 2001NoNoNoRXAKORN OPERATING CO LLCc15e02baa4c26aec2a728acedb6e378c1abc7be08fcf90181ef51eec337a7b1b
4677A065028002RIFAMPINCAPSULE;ORALCAPSULEORALRIFAMPINAKORN300MGAB["AB"]2001-03-14Mar 14, 2001NoNoNoRXAKORN OPERATING CO LLC7769aef14a400fe8ebc67852800ea5ef8cc86b4185b20305a09f0ee68341887e
4678A065390001RIFAMPINCAPSULE;ORALCAPSULEORALRIFAMPINLANNETT CO INC150MGAB["AB"]2008-03-28Mar 28, 2008NoNoNoRXLANNETT CO INC62cd73d937eae2e4bb7f18bbbbf890f633b007c0c3687afc7b4eca7f5746f21c
4679A065390002RIFAMPINCAPSULE;ORALCAPSULEORALRIFAMPINLANNETT CO INC300MGAB["AB"]2008-03-28Mar 28, 2008NoNoNoRXLANNETT CO INC87a538e84bd6eea59151cb55eb4290172c6d01e90422759ec2afc298f501e1af
4680A090034001RIFAMPINCAPSULE;ORALCAPSULEORALRIFAMPINLUPIN PHARMS150MGAB["AB"]2013-08-21Aug 21, 2013NoNoNoRXLUPIN PHARMACEUTICALS INCed1bd47337c1c18190a644d7b4707fdfd1bb61bf4eefacf4b7839d6d57803517
4681A090034002RIFAMPINCAPSULE;ORALCAPSULEORALRIFAMPINLUPIN PHARMS300MGAB["AB"]2013-08-21Aug 21, 2013NoNoYesRXLUPIN PHARMACEUTICALS INCa520e2c9ea9a4ef6dff3e50340ba105b950d9500e9d0d490f27b7bc3cf8fd5e2
4682A064150002RIFAMPINCAPSULE;ORALCAPSULEORALRIFAMPINSANDOZ150MGAB["AB"]1998-01-02Jan 2, 1998NoNoNoRXSANDOZ INC4e36d66eaca220f49afb0fd94db75e685ff117dec33950a2903a8e73c320ad4f
4683A064150001RIFAMPINCAPSULE;ORALCAPSULEORALRIFAMPINSANDOZ300MGAB["AB"]1997-05-28May 28, 1997NoNoNoRXSANDOZ INCb76acb61d1d2ccb95ce7929687bc5ba21d265684cba46398f5ce72002077ad39
4684A065221001ISONIAZID; RIFAMPINCAPSULE;ORALCAPSULEORALRIFAMPIN AND ISONIAZIDHIKMA INTL PHARMS150MG;300MG[]2005-07-29Jul 29, 2005NoNoNoDISCNHIKMA INTERNATIONAL PHARMACEUTICALS LLC937a97344e449dc5d83a085504e3604408a5b6c540dc09488e6aa1d4715073de
4685N050429001RIFAMPINCAPSULE;ORALCAPSULEORALRIMACTANEOXFORD PHARMS300MGAB["AB"]Approved Prior to Jan 1, 1982YesNoNoRXOXFORD PHARMACEUTICALS LLCc6383073dd369559b1fd90505dd403ca3a638cf1676428a57aa24f43389bccbe
4686A205801001RITONAVIRCAPSULE;ORALCAPSULEORALRITONAVIRHIKMA100MG[]2020-12-03Dec 3, 2020NoNoNoDISCNHIKMA PHARMACEUTICALS USA INC0e602239e9d48439f6fb9fc0707df4d8c4927da4958b4c8455ded00f6ac9ea13
4687A091689001RIVASTIGMINE TARTRATECAPSULE;ORALCAPSULEORALRIVASTIGMINE TARTRATEALEMBIC PHARMS LTDEQ 1.5MG BASEAB["AB"]2012-06-12Jun 12, 2012NoNoNoRXALEMBIC PHARMACEUTICALS LTD5cea51eec12b4969652430710513b01fefa896e16462d307d2f4fa355688c22c
4688A091689002RIVASTIGMINE TARTRATECAPSULE;ORALCAPSULEORALRIVASTIGMINE TARTRATEALEMBIC PHARMS LTDEQ 3MG BASEAB["AB"]2012-06-12Jun 12, 2012NoNoNoRXALEMBIC PHARMACEUTICALS LTD86f1609d1e7e858209eab5169fae155328bce710441773971bdd2c92c820ecd9
4689A091689003RIVASTIGMINE TARTRATECAPSULE;ORALCAPSULEORALRIVASTIGMINE TARTRATEALEMBIC PHARMS LTDEQ 4.5MG BASEAB["AB"]2012-06-12Jun 12, 2012NoNoNoRXALEMBIC PHARMACEUTICALS LTDf425de7885b53469931e58a194736c2c7913f60afdd0bd1d9c5c13c6cc388cf1
4690A091689004RIVASTIGMINE TARTRATECAPSULE;ORALCAPSULEORALRIVASTIGMINE TARTRATEALEMBIC PHARMS LTDEQ 6MG BASEAB["AB"]2012-06-12Jun 12, 2012NoNoNoRXALEMBIC PHARMACEUTICALS LTDf19d26e6879d5287fac5c90e8c82c35c3ddfb45c21c9123b76b818dab9d69a47
4691A091072001RIVASTIGMINE TARTRATECAPSULE;ORALCAPSULEORALRIVASTIGMINE TARTRATEAPOTEX INCEQ 1.5MG BASE[]2013-05-16May 16, 2013NoNoNoDISCNAPOTEX INC24a236e01e1bf03b112f72de0e0b650e43322c9d5e71f01840dde03f121a977d
4692A091072002RIVASTIGMINE TARTRATECAPSULE;ORALCAPSULEORALRIVASTIGMINE TARTRATEAPOTEX INCEQ 3MG BASE[]2013-05-16May 16, 2013NoNoNoDISCNAPOTEX INC62bc8ded923ee9ce4c7464997487d3eb8c3ff6c236f403508f6dd1e55d12b7f5
4693A091072003RIVASTIGMINE TARTRATECAPSULE;ORALCAPSULEORALRIVASTIGMINE TARTRATEAPOTEX INCEQ 4.5MG BASE[]2013-05-16May 16, 2013NoNoNoDISCNAPOTEX INC79206915f2c254bab8fb22f9bbbc9db91515691763d3be9c115842c8cfc322b9
4694A091072004RIVASTIGMINE TARTRATECAPSULE;ORALCAPSULEORALRIVASTIGMINE TARTRATEAPOTEX INCEQ 6MG BASE[]2013-05-16May 16, 2013NoNoNoDISCNAPOTEX INC23bc02a0e4645163c4ac8a5437498311a02677983927c1fd01a8a68275fb49a5
4695A204572001RIVASTIGMINE TARTRATECAPSULE;ORALCAPSULEORALRIVASTIGMINE TARTRATEAUROBINDO PHARMA LTDEQ 1.5MG BASEAB["AB"]2016-03-25Mar 25, 2016NoNoNoRXAUROBINDO PHARMA LTDa012c8cc4a44214ec41c4b24d58d31bfc16c90470f26f3899263442548bb030d
4696A204572002RIVASTIGMINE TARTRATECAPSULE;ORALCAPSULEORALRIVASTIGMINE TARTRATEAUROBINDO PHARMA LTDEQ 3MG BASEAB["AB"]2016-03-25Mar 25, 2016NoNoNoRXAUROBINDO PHARMA LTDfcff09aff0f6906f5b79daffc03499d5b9382d74403d7db0772543cce1dc8a23
4697A204572003RIVASTIGMINE TARTRATECAPSULE;ORALCAPSULEORALRIVASTIGMINE TARTRATEAUROBINDO PHARMA LTDEQ 4.5MG BASEAB["AB"]2016-03-25Mar 25, 2016NoNoNoRXAUROBINDO PHARMA LTDfce65f9d7e9d097786da8e2ceb5529941bcd4dd46f22b2049a9af9d05f044b43
4698A204572004RIVASTIGMINE TARTRATECAPSULE;ORALCAPSULEORALRIVASTIGMINE TARTRATEAUROBINDO PHARMA LTDEQ 6MG BASEAB["AB"]2016-03-25Mar 25, 2016NoNoNoRXAUROBINDO PHARMA LTDd6c2b3b74edd1df784830bbf2a09e00265b330466b55c0a097e60274a720d184
4699A203844001RIVASTIGMINE TARTRATECAPSULE;ORALCAPSULEORALRIVASTIGMINE TARTRATECADILA PHARMS LTDEQ 1.5MG BASEAB["AB"]2017-02-13Feb 13, 2017NoNoNoRXCADILA PHARMACEUTICALS LTD4b97d645ecae5b18324446cec4ba9f9b461291b351fa9b1aea78f685f5db2aac
4700A203844002RIVASTIGMINE TARTRATECAPSULE;ORALCAPSULEORALRIVASTIGMINE TARTRATECADILA PHARMS LTDEQ 3MG BASEAB["AB"]2017-02-13Feb 13, 2017NoNoNoRXCADILA PHARMACEUTICALS LTDb697f9f1fa74ab200139c2e0498052abd16e04127150368318b74ab9e7feb78c
4701A203844003RIVASTIGMINE TARTRATECAPSULE;ORALCAPSULEORALRIVASTIGMINE TARTRATECADILA PHARMS LTDEQ 4.5MG BASEAB["AB"]2017-02-13Feb 13, 2017NoNoNoRXCADILA PHARMACEUTICALS LTDf288dfc64492361fbe676ebd27d8bde4cea068cef82db1df1db702d5f8d9ec94